Endocardial TIE1 synergizes with TIE2 to regulate the atrial internal muscular network assembly

This study demonstrates that endocardial TIE1 acts in synergy with TIE2 to regulate the assembly of the atrial internal muscular network, revealing a critical and differential role for TIE1 in atrial versus ventricular development that becomes apparent when combined with TIE2 insufficiency.

The Gist

The Big Picture: Building a Heart that Beats Right

Imagine the heart is a house being built. The ventricles (the bottom rooms) are the heavy-duty living rooms where the main work happens, and they get built first. The atria (the top rooms) are like the entryways or foyers.

For a house to be strong and functional, the walls inside these rooms can't just be smooth flat surfaces. They need trabeculae—think of these as the internal wooden beams, scaffolding, or "muscular networks" that give the walls strength, texture, and the ability to pump efficiently.

This study is about two specific "foremen" (proteins called TIE1 and TIE2) who are in charge of building these internal beams. The researchers discovered something surprising: these foremen are much more important for building the atria (the top rooms) than the ventricles, and they work best when they hold hands.

---

The Cast of Characters

1. The Endocardium (The Inner Lining): Imagine the inside of the heart is lined with a special, sticky wallpaper. This is the endocardium. It doesn't just sit there; it talks to the muscle cells (the workers) and tells them, "Hey, build a beam right here!"
2. TIE1 and TIE2 (The Foremen): These are two proteins (molecular managers) living on that inner wallpaper.
   • TIE2 is the loud, experienced foreman who has been studied for a long time.
   • TIE1 is the quieter, newer foreman. We knew it helped with lymph nodes (the body's drainage system), but we didn't know much about its role in the heart.
3. The "Synergy" (The Power Couple): The study found that TIE1 and TIE2 are like a dynamic duo. TIE1 is the "glue" that helps TIE2 work properly. Without TIE1, TIE2 gets confused and can't do its job well.

---

The Discovery: The "Top Room" Problem

The researchers used a high-tech microscope (single-cell RNA sequencing) to look at the heart cells of developing mouse embryos. They found a fascinating pattern:

• The "Volume" Difference: The blueprints for TIE1 and TIE2 were turned up to "maximum volume" in the atria (top rooms) but were much quieter in the ventricles (bottom rooms).
• The Construction Site: When the researchers removed TIE1 from the mice, the atria stopped building their internal beams entirely. The walls remained smooth and weak, like a room with no support beams.
• The Ventricles were Fine (At First): Surprisingly, the bottom rooms (ventricles) looked mostly normal when TIE1 was missing. They could still build their beams, just not as perfectly as the top rooms.

The Analogy: Imagine you are building a house. You fire the "Atrium Foreman" (TIE1). The entryway (atrium) immediately stops getting its support beams and collapses into a smooth, useless wall. But the living room (ventricle) keeps building its beams because it has a backup plan.

---

The "Double Trouble" Experiment

The researchers wanted to see what happens if they mess with both foremen. They created a scenario where TIE1 was missing, and TIE2 was only half-present (like having a foreman with only one arm).

• The Result: Disaster. Both the top rooms (atria) and the bottom rooms (ventricles) failed to build their internal beams. The heart became a smooth, weak sac that couldn't pump blood effectively.
• The Timing: This failure happened incredibly fast. Within just 48 hours of removing the foremen, the atrial beams were gone. This proved that the inner lining (endocardium) is the immediate boss telling the muscle where to build.

---

Why Does This Matter?

1. It Explains "Atrial Cardiomyopathy": Many people have heart problems where the top chambers (atria) get weak and enlarged, leading to irregular heartbeats (arrhythmias). This study suggests that if the "TIE1/TIE2" communication line is broken, the atrial walls can't build their internal support network, leading to these diseases.
2. It's Not Just About Lymphedema: We knew TIE1 mutations caused lymphedema (swelling due to bad drainage). Now we know these patients might also have hidden heart defects, specifically in the atria, that doctors should check for.
3. The "Teamwork" Lesson: The heart doesn't rely on just one manager. It relies on a team. TIE1 and TIE2 work together to ensure the heart's internal architecture is complex and strong.

The Takeaway

Think of the heart's internal structure as a complex web of bridges and beams. TIE1 is the silent partner that makes sure TIE2 knows exactly where to build these bridges in the atria. Without TIE1, the atria lose their structural integrity, becoming smooth and weak, while the ventricles struggle to keep up.

This research gives us a new map for understanding how hearts are built and why they sometimes fail, pointing toward new ways to treat heart diseases that specifically affect the upper chambers.

Technical Summary

1. Problem Statement

• Clinical Context: Atrial cardiomyopathy involves altered atrial structures, yet the genetic basis and molecular mechanisms underlying these disorders remain poorly understood. While TIE1 variants are known to cause lymphedema, their potential role in cardiac defects is unclear.
• Scientific Gap: The dynamic processes and regulatory networks governing atrial trabeculation (the formation of the internal muscular network, or pectinate muscles) are inadequately elucidated compared to ventricular trabeculation.
• Specific Question: How do endothelial receptors TIE1 and TIE2 (encoded by Tek) function in cardiac chamber morphogenesis, and do they exhibit differential requirements between the atria and ventricles?

2. Methodology

The study employed a multi-faceted approach combining bioinformatics, genetic mouse models, and molecular biology techniques:

• Bioinformatics Analysis:
  • Re-analyzed published single-cell RNA sequencing (scRNA-seq) data (Feng et al., 2022) covering murine embryonic stages (E10.5–E18.5) to map Tie1 and Tek expression in endocardial cells.
  • Performed bulk RNA-seq on dissected atria and ventricles from Tie1 mutant and control mice to identify differential gene expression.
  • Used CellChat for ligand-receptor interaction analysis (specifically ANGPT1-TIE2 signaling).
• Genetic Mouse Models:
  • Constitutive Knockouts: Tie1^tm1a/tm1a (knockout-first) and Tie1^ΔICD/ΔICD (kinase domain deletion).
  • Conditional/Inducible Models: Used Cdh5-CreERT2 (endothelial-specific) to induce gene deletion at specific developmental windows.
  • Combinatorial Models: Generated double mutants (Tie1^ΔICD/ΔICD; Tek^+/-) and inducible double mutants (Tie1^iECKO; Tek^+/-) to test synergy.
  • Induction Strategy: Tamoxifen administration at embryonic days (E10.5, E12.5) and postnatal days (P1) to achieve temporal control of gene deletion.
• Phenotypic Analysis:
  • Immunostaining: Whole-mount and section staining for Endomucin (EMCN) to visualize trabeculae, PECAM1 for coronary vessels, and TIE1/DLL4 for receptor expression.
  • Quantification: Measured trabecular area (EMCN+), coronary vessel density (PECAM1+), ventricular wall thickness, and heart-to-body ratio.
  • Fractal Analysis: Used ImageJ (Fraclac plugin) to quantify the complexity of trabecular networks.
  • RNA-seq: Bulk sequencing of whole hearts and separated atria/ventricles to analyze transcriptomic changes.

3. Key Contributions

• Discovery of Differential Expression: Demonstrated that Tie1 and Tek transcripts are significantly higher in atrial endocardial cells compared to ventricular endocardial cells during early development (up to E14.5).
• Identification of Synergy: Revealed that TIE1 and TIE2 act synergistically; while Tie1 deficiency alone causes mild defects, the combination of Tie1 loss and Tek heterozygosity leads to severe, early embryonic lethality and profound morphological defects.
• Temporal Specificity: Showed that the atrial internal muscular network is uniquely sensitive to TIE signaling, with defects detectable as early as 48 hours after induced endothelial deletion, preceding severe ventricular defects.
• Mechanistic Insight: Linked TIE1/TIE2 synergy to the regulation of the NOTCH1 and DLL1 pathways and the COUP-TFII stability, which are critical for endocardial specification and trabeculation.

4. Key Results

A. Expression Patterns

• scRNA-seq and bulk RNA-seq confirmed that Tie1 and Tek are highly expressed in atrial endocardium.
• Angpt1 (ligand for TIE2) was found to be highly expressed in atrial cardiomyocytes, suggesting a strong ANGPT1-TIE2 paracrine loop specifically in the atria.

B. Phenotypic Consequences of Tie1 Deficiency

• Atria: Tie1 mutants exhibited a near-complete absence of atrial trabeculae (pectinate muscles) by E14.5 and E17.5.
• Ventricles: Ventricular trabeculation was less affected initially, showing only sparse structures at E14.5, with more severe disorganization appearing at later stages (E17.5).
• Coronary Vasculature: Tie1 deficiency led to reduced coronary vessel density and defective coronary vein formation.

C. Synergy between TIE1 and TIE2

• Double Heterozygosity: Mice with Tie1 deficiency combined with one null Tek allele (Tie1^ΔICD/ΔICD; Tek^+/-) showed severe defects at E10.5, including reduced heart size and failed chamber formation, leading to lethality before E12.5.
• Induced Deletion: In inducible models (Tie1^iECKO; Tek^+/-), deleting genes at E12.5 resulted in absent atrial trabeculae within 48 hours (E14.5), while ventricular defects remained mild at this early time point.
• Postnatal Validation: In postnatal models (P1–P21), Tie1 insufficiency alone had no effect, but the Tie1^iECKO; Tek^+/- combination caused significant atrial trabecular defects and reduced heart weight, confirming the synergistic requirement persists into postnatal remodeling.

D. Transcriptomic Mechanisms

• Gene Downregulation: Loss of Tie1 led to significant downregulation of Tek, Dll1, Notch1, Nrg1, and Adgrg6 in the atria.
• Pathway Analysis: Gene Set Enrichment Analysis (GSEA) showed downregulation of pathways related to endothelial migration, extracellular matrix (ECM) organization, and trabeculation.
• Atrial vs. Ventricular Specificity: The downregulation of trabeculation-related genes was more pronounced in the atria than in the ventricles. Notch1 was downregulated specifically in the atria of mutants.

5. Significance

• Novel Mechanism for Atrial Cardiomyopathy: The study provides a genetic and molecular explanation for atrial structural defects, linking them to the TIE1/TIE2 signaling axis. This suggests that patients with TIE1 mutations (previously associated only with lymphedema) may also be at risk for atrial structural abnormalities.
• Differential Chamber Regulation: It challenges the view of uniform cardiac development, highlighting that atrial and ventricular morphogenesis rely on distinct sensitivities to endothelial signaling.
• Therapeutic Implications: Understanding the synergy between TIE1 and TIE2 offers new targets for preventing or treating congenital heart defects involving atrial hypoplasia or non-compaction.
• Endocardial-Myocardial Crosstalk: The findings reinforce the critical role of the endocardium in organizing the myocardial internal network, specifically through the modulation of NOTCH1 and ECM dynamics.

In summary, this paper establishes that TIE1 is differentially required for atrial development and acts in synergy with TIE2 to regulate the assembly of the atrial internal muscular network, primarily by maintaining the expression of key signaling molecules like Tek, Dll1, and Notch1 in the atrial endocardium.